tradingkey.logo
tradingkey.logo
Search

TherapeuticsMD Inc

TXMD
Add to Watchlist
2.160USD
-0.050-2.26%
Close 07/01, 16:00ETQuotes delayed by 15 min
25.00MMarket Cap
138.82P/E TTM

TherapeuticsMD Inc

2.160
-0.050-2.26%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-2.26%

5 Days

+7.46%

1 Month

+1.89%

6 Months

+32.52%

Year to Date

+32.52%

1 Year

+91.15%

Key Figures
2.210Open
2.320High
36.09KVolume
138.82P/E TTM
--P/E Dynamic
--Dividend TTM
0.31%Turnover Ratio
2.210Prev. Close
2.155Low
65.51KTurnover
LossP/E Static
0.93P/B
0.00%Div Yield TTM
0.23%ROA
2.95052wk High
0.92Volume Ratio
-2.18MNet Profit
11.57MShares
0.0156EPS TTM
0.60Beta
0.32%ROE
0.98152wk Low
7.47%Amplitude
100.00%Gross Margin
25.00MMarket Cap
1.71Reward/Risk
4.87%Risk Rate

TradingKey Stock Score of TherapeuticsMD Inc

Currency: USD Updated: 2026-06-30

Key Insights

TherapeuticsMD Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 113 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

TherapeuticsMD Inc's Score

Industry at a Glance

Industry Ranking
113 / 157
Overall Ranking
356 / 4569
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

TherapeuticsMD Inc Highlights

StrengthsRisks
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 132.10% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.02M.
Overvalued
The company’s latest PE is 142.03, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 3.82M shares, increasing 9.99% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.51.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space

TherapeuticsMD Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

TherapeuticsMD Inc Info

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Ticker SymbolTXMD
CompanyTherapeuticsMD Inc
CEOWalker (Marlan D)
Websitehttps://www.therapeuticsmd.com/

FAQs

What is the current price of TherapeuticsMD Inc (TXMD)?

The current price of TherapeuticsMD Inc (TXMD) is 2.16.

What is the symbol of TherapeuticsMD Inc?

The ticker symbol of TherapeuticsMD Inc is TXMD.

What is the 52-week high of TherapeuticsMD Inc?

The 52-week high of TherapeuticsMD Inc is 2.95.

What is the 52-week low of TherapeuticsMD Inc?

The 52-week low of TherapeuticsMD Inc is 0.98.

What is the market capitalization of TherapeuticsMD Inc?

The market capitalization of TherapeuticsMD Inc is 25.00M.

What is the Earnings Per Share (EPS TTM) of TherapeuticsMD Inc (TXMD)?

The Earnings Per Share (EPS TTM) of TherapeuticsMD Inc (TXMD) is -0.05.